Verily Becomes Independent With $300 Million Raise, Unveils Samsung and Salesforce Partnerships
Alphabet shifts to a significant minority stake, positioning Verily to pursue vendor‑neutral collaborations.
Overview
- The company restructured into a corporation named Verily Health Inc. as part of its transition from Alphabet control.
- Series X Capital led the $300 million financing, with the fund focused on scaling former Google X projects under investor Gideon Yu.
- Verily says the capital will accelerate its AI‑native Pre platform to harmonize fragmented health data and embed intelligence in clinical workflows.
- New commercial agreements include work with Samsung to use Galaxy Watch data for biomarker development and an integration of the Pre platform with Salesforce’s Agentforce Health.
- UCHealth and the University of Colorado Anschutz joined the round and are using the Pre platform in clinical research and care delivery.